Understanding Breast Density and the Impact of the New FDA Requirement: How Aidoc and ScreenPoint Support MQSA Compliance
Aidoc
NOVEMBER 28, 2024
to inform patients of their breast density status. This article explores breast density, its implications for cancer screening, the FDA’s new rule and how Aidoc’s partnership with ScreenPoint supports clinicians in meeting these standards through the Transpara Breast Density solution. Citations 1 Sprague, Conant, et.
Let's personalize your content